TI
Tidal Investments’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
8,327
-3,760
| -31% | -$473K | 0.01% | 983 |
|
|
2025
Q1 | $1.34M | Buy |
12,087
+2,662
| +28% | +$294K | 0.01% | 834 |
|
|
2024
Q4 | $1.29M | Sell |
9,425
-5,618
| -37% | -$767K | 0.01% | 863 |
|
|
2024
Q3 | $1.73M | Buy |
15,043
+5,197
| +53% | +$599K | 0.02% | 716 |
|
|
2024
Q2 | $1.36M | Buy |
9,846
+304
| +3% | +$41.9K | 0.02% | 729 |
|
|
2024
Q1 | $1.32M | Buy |
9,542
+3,497
| +58% | +$482K | 0.02% | 740 |
|
|
2023
Q4 | $796K | Buy |
6,045
+3,940
| +187% | +$519K | 0.02% | 727 |
|
|
2023
Q3 | $237K | Buy |
+2,105
| New | +$237K | 0.01% | 1148 |
|
|
2023
Q2 | – | Sell |
-2,057
| Closed | -$208K | – | 1361 |
|
|
2023
Q1 | $208K | Buy |
+2,057
| New | +$208K | 0.01% | 1178 |
|
|
2022
Q2 | – | Sell |
-3,144
| Closed | -$295K | – | 1157 |
|
|
2022
Q1 | $295K | Buy |
3,144
+402
| +15% | +$37.7K | 0.01% | 824 |
|
|
2021
Q4 | $234K | Buy |
2,742
+490
| +22% | +$41.8K | 0.01% | 849 |
|
|
2021
Q3 | $216K | Buy |
+2,252
| New | +$216K | 0.01% | 769 |
|
|
2021
Q2 | – | Sell |
-2,579
| Closed | -$251K | – | 739 |
|
|
2021
Q1 | $251K | Buy |
+2,579
| New | +$251K | 0.01% | 478 |
|
|
2020
Q3 | – | Sell |
-2,246
| Closed | -$274K | – | 295 |
|
|
2020
Q2 | $274K | Buy |
+2,246
| New | +$274K | 0.04% | 238 |
|